Uncategorized

Cure SMA Statement on Tax Reform Bill and the Repeal of the Individual Mandate

December 21, 2017
Posted in

On Wednesday, Congress passed the most sweeping tax bill in a generation. Cure SMA has been monitoring and advocating on your behalf as this legislation […]

Read More ›

Cure SMA Announces $5.05 Million in Research Funding for FY18

September 19, 2017
Posted in

Over the past fiscal year—from July 1, 2016, to June 30, 2017—Cure SMA has funded over $2.5 million in new research funding. This funding will […]

Read More ›

Biogen Completes Rolling Submission of New Drug Application to FDA

September 26, 2016
Posted in

Biogen and Ionis today announced that Biogen has completed the rolling submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration […]

Read More ›
Scroll to Top